0000884905-18-000082.txt : 20181102 0000884905-18-000082.hdr.sgml : 20181102 20181102110043 ACCESSION NUMBER: 0000884905-18-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181031 FILED AS OF DATE: 20181102 DATE AS OF CHANGE: 20181102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strauss David P CENTRAL INDEX KEY: 0001705851 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11037 FILM NUMBER: 181155902 MAIL ADDRESS: STREET 1: 10 RIVERVIEW DRIVE CITY: DANBURY STATE: CT ZIP: 06810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRAXAIR INC CENTRAL INDEX KEY: 0000884905 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INORGANIC CHEMICALS [2810] IRS NUMBER: 061249050 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 RIVERVIEW DRIVE CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 2038372000 MAIL ADDRESS: STREET 1: 10 RIVERVIEW DRIVE CITY: DANBURY STATE: CT ZIP: 06810 FORMER COMPANY: FORMER CONFORMED NAME: UNION CARBIDE INDUSTRIAL GASES INC DATE OF NAME CHANGE: 19600201 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-10-31 1 0000884905 PRAXAIR INC PX 0001705851 Strauss David P C/O PRAXAIR, INC. 10 RIVERVIEW DRIVE DANBURY CT 06810 0 1 0 0 Vice President Human Resources Common Stock 2018-10-31 4 D 0 1625.6827 0 D 0 I 401(k) Common Stock 2018-10-31 4 D 0 8778.943 0 D 0 D Restricted Stock Units 0 2018-10-31 4 D 0 2720 0 D Common Stock 2720 0 D Restricted Stock Units 0 2018-10-31 4 D 0 570 0 D Common Stock 570 0 D Restricted Stock Units 0 2018-10-31 4 D 0 2168 0 D Common Stock 2168 0 D Restricted Stock Units 0 2018-10-31 4 D 0 585 0 D Common Stock 585 0 D Restricted Stock Units 0 2018-10-31 4 D 0 1490 0 D Common Stock 1490 0 D Stock Option (right to buy) 60.92 2018-10-31 4 D 0 5220 D 2019-02-24 Common Stock 5220 0 D Stock Option (right to buy) 76.16 2018-10-31 4 D 0 3070 D 2020-02-23 Common Stock 3070 0 D Stock Option (right to buy) 97.84 2018-10-31 4 D 0 3630 D 2021-02-22 Common Stock 3630 0 D Stock Option (right to buy) 109.68 2018-10-31 4 D 0 4610 D 2022-02-28 Common Stock 4610 0 D Stock Option (right to buy) 110.58 2018-10-31 4 D 0 4255 D 2023-02-26 Common stock 4255 0 D Stock Option (right to buy) 128.80 2018-10-31 4 D 0 4305 D 2024-02-25 Common Stock 4305 0 D Stock Option (right to buy) 128.38 2018-10-31 4 D 0 5150 D 2025-02-24 Common Stock 5150 0 D Stock Option (right to buy) 102.22 2018-10-31 4 D 0 7955 D 2026-02-23 Common Stock 7955 0 D Stock Option (right to buy) 118.71 2018-10-31 4 D 0 19815 D 2027-02-28 Common Stock 19815 0 D Stock Option (right to buy) 154.00 2018-10-31 4 D 0 22635 D 2028-02-27 Common Stock 22635 0 D Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. that will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Anthony M. Pepper, Attorney-in-Fact 2018-11-02